SCHEMBL28037697

SCHEMBL28037697

NC(=O)Cc1ccc(F)cc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA3 P07451 1/20 0.45
CA6 P23280 1/20 0.45
CA5A P35218 1/20 0.45
CA9 Q16790 1/20 0.45
CA14 Q9ULX7 1/20 0.45
CA5B Q9Y2D0 1/20 0.45
ICMT O60725 3/20 0.44
MPO P05164 2/20 0.43
SLC6A4 P31645 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ANO1 Q5XXA6 2/20 0.41
CA2 P00918 1/20 0.41
TSHR P16473 1/20 0.40
GAA P10253 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
XBP1 P17861 1/20 0.40
HIF1A Q16665 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1115269 0.84 MAPK8 (0.52) ICMTMPOSLC6A4MAPK8KDM4E
SCHEMBL30148003 0.84 MAPK8 (0.52) ICMTMPOSLC6A4MAPK8KDM4E
SCHEMBL2395772 0.83 TSHR (0.54) CA3CA6CA5ACA9CA14
Hydrochloric Acid SCHEMBL8894497 0.82 IDO1 (0.52) ICMTMPOSLC6A4MAPK8KDM4E
SCHEMBL28875498 0.82 MEN1 (0.58) MEN1KMT2ACA2
SCHEMBL1395757 0.81 ALDH1A1 (0.44) ICMTMPOSLC6A4MEN1KMT2A
SCHEMBL1345638 0.81 P2RX7 (0.45) ICMTMPOSLC6A4MAPK8
SCHEMBL14495394 0.81 P2RX7 (0.47) ICMTMPOSLC6A4HTT
SCHEMBL29718887 0.81 ALDH1A1 (0.44) ICMTMPOSLC6A4MEN1KMT2A
SCHEMBL1115079 0.80 MAPK8 (0.52) CA3CA6CA5ACA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105164124-B Compounds and compositions for treating parasitic diseases 诺华股份有限公司 2017-03-15 CN disclosed
CN-105164124-A Compounds and compositions for treating parasitic diseases NOVARTIS AG 2015-12-16 CN disclosed